Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMIPRIL vs RANIBIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMIPRIL vs RANIBIZUMAB: Safety Overview

Metric RAMIPRIL RANIBIZUMAB
Total FAERS Reports 33,063 15,284
Deaths Reported 3,786 2,651
Death Rate 11.5% 17.3%
Hospitalizations 17,747 2,265
Average Patient Age 65.4 yrs 71.7 yrs
% Female Patients 53.1% 52.5%
FDA Approval Date Apr 15, 2014 N/A
Manufacturer GSMS, Incorporated Coherus BioSciences Inc
Route ORAL INTRAVITREAL
Marketing Status Discontinued Prescription